The mouse lymphoma L5178Y Tk(+/-) cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 373, Issue 2, 1997, Pages 157-165

  Storer, Richard D ^a   Kraynak, Andrew R ^a   McKelvey, Troy W ^a   Elia, Michael C ^b,d   Goodrow, Tamra L ^c   DeLuca, John G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ROHM AND HAAS COMPANY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d Astra Merck Inc   (United States)

Author keywords

Mouse lymphoma L5178Y cell; p53 mutation

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL CELL; ARTICLE; CELL CLONE; CELL LINE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GAMMA RADIATION; GENETIC ANALYSIS; IMMUNOBLOTTING; LEUKEMIA L 5178 Y; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPLEEN CELL;

ANIMALS; CARCINOGENICITY TESTS; CELL LINE; CODON; DNA DAMAGE; GENES, P53; HETEROZYGOTE; LEUKEMIA L5178; MICE; MODELS, GENETIC; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

ANIMALIA;

EID: 0030697498     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(96)00227-8     Document Type: Article

References (36)

1. Clive, D., W.G. Flamm, M.R. Machesko and N.J. Bernheim (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells, Mutation Res., 16, 77-87.
2. Clive, D. and P. Voytek (1977) Evidence for chemically-induced structural gene mutations at the thymidine kinase locus in cultured mouse lymphoma cells, Mutation Res., 44, 269-278.
3. +/- mouse lymphoma mutagen assay system, Mutation Res., 59, 61-108.
4. -/- mouse lymphoma cell mutagenicity assay, in: B.J. Kilbey, M.S. Legator, W. Nichols and C. Ramel (Eds.), Handbook of Mutagenicity Test Procedures, Elsevier, Amsterdam, pp. 239-268.
5. +/- mouse lymphoma cells, Environ. Mol. Mutagen., 12, 265-268.
6. Caldwell, J. (1993) Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: Ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens. Teratogen. Carcinogen. Mutagen., 13, 185-190.
7. Garriott, M.L., D.A. Casciano, L.M. Schectman and G.S. Probst (1995) International workshop on mouse lymphoma testing practices and data interpretations: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 162-164.
8. Clive, D., G. Bolcsfoldi, J. Clements, J. Cole, M. Homna, J. Majeska, M. Moore, L. Muller, B. Myhr, T. Oberly, M.-C. Oudelhkim, C. Rudd, H. Shimada, T. Sofuni, V. Thybaud and P. Wilcox (1995) Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 165-168.
9. +/- mouse lymphoma assay. Environ. Mol. Mutagen., 27, 75-78.
10. Ashby, J and R.W. Tennant (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res., 257, 229-306.
11. Storer, R.D., T.W. McKelvey, A.R. Kraynak, M.C. Elia, J.E. Barnum, L.S. Harmon, W.W. Nichols and J.G. Deluca (1996) Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: Improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds, Mutation Res., 368, 59-101.
12. Radford, I.R. and T.K. Murphy (1994) Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to cell killing by DNA double-strand breakage, Int. J. Radiat. Biol., 65, 229-239.
13. Radford, I.R. (1994) p53 status, double-strand break repair proficiency and radiation response of mouse lymphoid and myeloid cell lines, Int. J. Radiat. Biol., 66(5), 557-560.
14. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein and R.W. Craig (1991) Participation of p53 protein in the cellular response to DNA damage, Cancer Res., 51, 6304-6311.
15. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne and T. Jacks (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature, 362, 847-849.
16. Lowe, S.W., H.E. Ruley, T. Jacks and D. Housman (1993) p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents, Cell, 74, 957-967.
17. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper and A.M. Wylie (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 849-851.
18. Xia, F., Y-H. Wang, N-M. Tsang, D.W. Yandell, K.T. Kelsey and H.L. Liber (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related lymphoblastoid cell lines, Cancer Res., 55, 12-15.
19. Schwartz, J.L., R. Jordan, B.A. Sedita, M.J. Swenningson, J.P. Banath and P.L. Olive (1995) Different sensitivity to cell killing and chromosome mutation induction by gamma rays in two human lymphoblastoid cell lines derived from a single donor: Possible role of apoptosis, Mutagenesis, 10, 227-233.
20. - cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Environ. Mol. Mutagen, 27 (Suppl. 27), 66.
21. Meese, E. and N. Blin (1987) Simultaneous isolation of high molecular weight RNA and DNA from limited amounts of tissues and cells, Genet. Anal. Tech., 4, 45-49.
22. Nicolaides, N.C. and C.J. Stoekert Jr. (1990) A simple, efficient method for the separate isolation of RNA and DNA from the same cells, Biotechniques, 8(2), 154-155.
23. Hegi, M.E., P. Söderkvist, J.F. Foley, R. Schoonhoven, J.A. Swenberg, F. Kari, R. Maronpot, M.W. Anderson and R.W. Wiseman (1993) Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice, Carcinogenesis, 14(5), 803-810.
24. Goodrow, T.L., R.D. Storer, K.R. Leander, S.R Prahalada, M.J. van Zwieten and M.O. Bradley (1992) Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors, Mol. Carcinogen., 5, 9-15.
25. Skopek, T.R., V.E. Walker, J.E. Cochrane, T.R. Craft and N.F. Cariello (1992) Mutational spectra of N-ethyl-N-nitrosourea at the HPRT locus in splenic T-cells of exposed B6C3F1 mice, Proc. Natl. Acad. Sci. USA, 89, 7866-7870.
26. Alexander, P. (1961) Mouse lymphoma cells with different radiosensitivities, Nature, 192, 572-573.
27. Beer, J.Z., E. Budzicka, E. Niepokojczycka, O. Rosie, I. Szumiel and M. Walicka, (1983) Loss of tumorigenicity with simultaneous changes in radiosensitivity and photosensitivity during in vitro growth of L5178Y murine lymphoma cells, Cancer Res., 43, 4736-4742, 1983.
28. Fischer, G.A. (1958) Studies of the culture of leukemic cells in vitro, Ann. NY Acad. Sci., 76, 673-680.
29. Lane, D.P. and S. Benchimol (1990) p53: oncogene or anti-oncogene?, Genes Dev., 4, 1-8.
30. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh and M.B. Kastan (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation, Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
31. Soussi, T., C. Caron de Fromentel and P. May (1990) Structural aspects of the p53 protein in relation to evolution, Oncogene, 5, 945-952.
32. Hainaut, P. and J. Milner (1993) A structural role for metal ions in the 'wild type' conformation of the tumor suppressor protein p53. Cancer Res., 53, 1739-1742.
33. Cho, Y., S. Gorina, P.D. Jeffrey, N.P. Pavletich (1994) Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations, Science, 265, 346-355.
34. Selvakumaran, M., H.K. Lin, T. Miyashita, H.G. Wang, S. Krajewski, J.C. Reed, B. Hoffman and D. Liebermann (1994) Immediate early upregulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways, Oncogene, 9(6), 1791-1798.
35. Cory, S., A. Strasser, T. Jacks, L.M. Corcoran, T. Metz, A.W. Harris and J.M. Adams (1994) Enhanced cell survival and tumorigenesis, Cold Spring Harbor Symposia on Quantitative Biology, 59, 365-377.
36. Elia, M.C., R.D. Storer, T.W. McKelvey, A.R. Kraynak, J.E. Barnum, L.S. Harmon, J.G. DeLuca and W.W. Nichols (1994) Rapid DNA degradation in primary rat hepatocytes treated with diverse cytotoxic chemcials. Environ. Mol. Mutagen., 24, 181-191.